UY29237A1 - METHODS OF TREATMENT AND PREVENTION - Google Patents

METHODS OF TREATMENT AND PREVENTION

Info

Publication number
UY29237A1
UY29237A1 UY29237A UY29237A UY29237A1 UY 29237 A1 UY29237 A1 UY 29237A1 UY 29237 A UY29237 A UY 29237A UY 29237 A UY29237 A UY 29237A UY 29237 A1 UY29237 A1 UY 29237A1
Authority
UY
Uruguay
Prior art keywords
prevention
treatment
methods
xylopyranoside
benzopyran
Prior art date
Application number
UY29237A
Other languages
Spanish (es)
Inventor
Jeffrey W Dubb
Linda S Henderson
Shunichiro S Okada
Vincent Peyrou
Robert E Samuels
Sunita Sheth
Patricia A Spera
John R Toomey
Douglas E Wilson
Original Assignee
Glaxo Group Ltd
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36565378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29237(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd, Fournier Lab Sa filed Critical Glaxo Group Ltd
Publication of UY29237A1 publication Critical patent/UY29237A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Se describen métodos para el tratamiento y/o la prevención de trastornos tromboembólicos, que comprenden administrar 4-metil-2-oxo-2H-1-benzopiran-7-il-5-tio-B(beta))-D-xilopiranósido en candidades eficaces.Methods for the treatment and / or prevention of thromboembolic disorders are described, which comprise administering 4-methyl-2-oxo-2H-1-benzopyran-7-yl-5-thio-B (beta)) - D-xylopyranoside in effective amounts.

UY29237A 2004-12-01 2005-11-29 METHODS OF TREATMENT AND PREVENTION UY29237A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63215304P 2004-12-01 2004-12-01
US69172805P 2005-06-17 2005-06-17
US72169105P 2005-09-29 2005-09-29
US72471005P 2005-10-07 2005-10-07

Publications (1)

Publication Number Publication Date
UY29237A1 true UY29237A1 (en) 2006-05-31

Family

ID=36565378

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29237A UY29237A1 (en) 2004-12-01 2005-11-29 METHODS OF TREATMENT AND PREVENTION

Country Status (5)

Country Link
AR (1) AR053789A1 (en)
PE (1) PE20061246A1 (en)
TW (1) TW200635580A (en)
UY (1) UY29237A1 (en)
WO (1) WO2006060647A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801055B1 (en) * 1999-11-17 2002-02-08 Fournier Ind & Sante BETA-D-5-THIOXYLOSE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE

Also Published As

Publication number Publication date
PE20061246A1 (en) 2006-11-08
AR053789A1 (en) 2007-05-23
WO2006060647A1 (en) 2006-06-08
TW200635580A (en) 2006-10-16

Similar Documents

Publication Publication Date Title
NL301145I2 (en) Tirbanibulin
CY1121135T1 (en) SUBSTITUTED FOUR-CYCLINES COMPOUNDS FOR THE TREATMENT OF INFLAMMATIVE SKIN DISORDERS
ECSP10010007A (en) TREATMENT WITH LIGANDOS ALPHA-7-SELECTIVOS
BRPI0717845A2 (en) Use of compounds, pharmaceutical compositions and methods for the treatment and / or prophylaxis of diseases that can be treated with HDL-cholesterol elevating agents and compounds.
CL2016002589A1 (en) Use of compound genz-112638 (eliglustat), glucosylceramide synthase inhibitor, in the treatment of gaucher disease and fabry disease (divisional application 201201348).
UY29796A1 (en) NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
MX2009006536A (en) Organic compounds and their uses.
ECSP077401A (en) MEDICATIONS CONTAINING CARBON COMPOUNDS AND THEIR USE
ECSP077421A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE ACTIVITY OF THE CANABINOID RECEIVER 1
MY147247A (en) Organic compounds and their uses
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
ECSP10010548A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
PL2134704T3 (en) Compounds and compositions as modulators of gpr119 activity
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
BRPI0416268A (en) delta-9-thc compositions and methods for treating symptoms associated with multiple sclerosis
BRPI0712607A8 (en) stroke treatment methods
DOP2009000165A (en) DERIVATIVES OF REPLACED OXINDOL, MEDICATIONS THAT UNDERSTAND AND USE THEMSELVES
CL2008000202A1 (en) Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain.
CL2009000803A1 (en) Use of a pegylated variant of igf-1 to treat, prevent a neuromuscular disorder; method for the treatment, prevention and / or delay of a neuromuscular disorder; composition comprising the modified igf-1 variant
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2009009417A3 (en) Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion
EP2069377A4 (en) Methods and compositions for the treatment of skin diseases and disorders
MX2008015775A (en) Compounds and compositions for treatment of cancer.
AR058173A1 (en) USE OF SDF-1 FOR THE TREATMENT AND / OR PREVENTION OF NEUROLOGICAL DISEASES
CY1111762T1 (en) OUTDOOR OUTDOOR OLANZAPIN